Lysine-Dendrimer, a New Non-Aggressive Solution to Rebalance the Microbiota of Acne-Prone Skin.

acne biofilm clinical studies dendrimer lysine microbial diversity

Journal

Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003

Informations de publication

Date de publication:
03 Aug 2023
Historique:
received: 27 06 2023
revised: 18 07 2023
accepted: 01 08 2023
medline: 26 8 2023
pubmed: 26 8 2023
entrez: 26 8 2023
Statut: epublish

Résumé

Acne is a chronic inflammatory skin disease that affects the quality of life of patients. Several treatments exist for acne, but their effectiveness tends to decrease over time due to increasing resistance to treatment and associated side effects. To circumvent these issues, a new approach has emerged that involves combating the pathogen

Identifiants

pubmed: 37631297
pii: pharmaceutics15082083
doi: 10.3390/pharmaceutics15082083
pmc: PMC10459463
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Nat Rev Microbiol. 2018 Mar;16(3):143-155
pubmed: 29332945
Sci Rep. 2022 Dec 6;12(1):21104
pubmed: 36473894
J Clin Microbiol. 2008 Oct;46(10):3355-60
pubmed: 18716234
Exp Dermatol. 2022 Jul;31(7):1056-1064
pubmed: 35231149
Science. 2014 Nov 21;346(6212):954-9
pubmed: 25414304
An Bras Dermatol. 2017 Mar-Apr;92(2):212-216
pubmed: 28538881
Br J Dermatol. 2019 Oct;181(4):691-699
pubmed: 31342510
Nat Rev Microbiol. 2011 Apr;9(4):244-53
pubmed: 21407241
Chemistry. 2010 Feb 15;16(7):2309-16
pubmed: 20033966
J Cutan Med Surg. 2022 Jan-Feb;26(1):93-97
pubmed: 34396785
Cochrane Database Syst Rev. 2020 Mar 16;3:CD011154
pubmed: 32175593
J Gen Microbiol. 1993 Aug;139(8):1745-51
pubmed: 8409917
Br J Dermatol. 2019 Oct;181(4):657-658
pubmed: 31515808
J Invest Dermatol. 2013 Sep;133(9):2152-60
pubmed: 23337890
Science. 2009 May 29;324(5931):1190-2
pubmed: 19478181
Expert Rev Dermatol. 2010 Apr;5(2):183-195
pubmed: 20473345
JAMA Dermatol. 2019 Apr 1;155(4):425-434
pubmed: 30758497
Microbiology (Reading). 2000 Oct;146 ( Pt 10):2395-2407
pubmed: 11021916
PLoS One. 2011;6(6):e21581
pubmed: 21738717
JAMA Dermatol. 2017 Sep 1;153(9):897-905
pubmed: 28538949
Am J Clin Dermatol. 2003;4(7):473-92
pubmed: 12814337
J Antibiot (Tokyo). 1984 Nov;37(11):1449-55
pubmed: 6392269
Drug Discov Today Dis Mech. 2013 Dec 1;10(3-4):
pubmed: 24273587
Microbiol Resour Announc. 2021 Jan 7;10(1):
pubmed: 33414288
J Am Acad Dermatol. 2008 Nov;59(5):792-800
pubmed: 18805603
Nat Biotechnol. 2007 Jun;25(6):657-9
pubmed: 17529972
Front Med (Lausanne). 2019 Jul 10;6:155
pubmed: 31355200
ISME J. 2008 Jul;2(7):689-95
pubmed: 18463690
Exp Dermatol. 2017 Sep;26(9):798-803
pubmed: 28094874
Sci Rep. 2016 Dec 21;6:39491
pubmed: 28000755
J Drugs Dermatol. 2013 Jun 01;12(6):s73-6
pubmed: 23839205
Genome Res. 2015 Oct;25(10):1514-20
pubmed: 26430162
Am Fam Physician. 2004 May 1;69(9):2123-30
pubmed: 15152959
Lancet. 2012 Jan 28;379(9813):361-72
pubmed: 21880356
Microbiologyopen. 2013 Dec;2(6):953-61
pubmed: 24151137
Am J Clin Dermatol. 2020 Sep;21(Suppl 1):18-24
pubmed: 32910436
Microbiome. 2018 Oct 2;6(1):177
pubmed: 30285861
Int J Dermatol. 2022 Oct;61(10):1205-1212
pubmed: 35521784

Auteurs

Julie Leignadier (J)

Lucas Meyer Cosmetics, 195 Route d'Espagne, 31036 Toulouse, France.

Marie Drago (M)

Shiseido EMEA, 56A Rue du Faubourg St Honoré, 75008 Paris, France.

Olivier Lesouhaitier (O)

Research Unit Bacterial Communication and Anti-Infectious Strategies (CBSA, UR4312), University of Rouen Normandie, 27000 Evreux, France.

Magalie Barreau (M)

Research Unit Bacterial Communication and Anti-Infectious Strategies (CBSA, UR4312), University of Rouen Normandie, 27000 Evreux, France.

Albert Dashi (A)

Sequential Skin Ltd., 85 Great Portland Street, London W1W 7LT, UK.

Oliver Worsley (O)

Sequential Skin Ltd., 85 Great Portland Street, London W1W 7LT, UK.

Joan Attia-Vigneau (J)

Lucas Meyer Cosmetics, 195 Route d'Espagne, 31036 Toulouse, France.

Classifications MeSH